← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2022-09-14

Drug application

FDA Application #

ANDA215675

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

PREGABALIN

Active ingredients

PREGABALIN

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

SCIEGEN PHARMS

Manufacturer

ScieGen Pharmaceuticals, INC.

First approval

2022-09-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown